This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
PillPack from Amazon Pharmacy has expanded access to Medicare Part D patients across the country, and this is huge because it means that millions of peoplemanaging multiple chronic conditions—and therefore juggling multiple medications—now have access to this service. It's exciting. Subscribe Now!
While an effective treatment for some people, Breo Ellipta may not be the best option for all peoplemanaging persistent asthma or COPD symptoms. Not all people with asthma will require a maintenance inhaler or a combination maintenance inhaler , and not all people with COPD will require a combination maintenance inhaler.
Many people are interested in a generic version of Ozempic (semaglutide), especially since the brand-name drug may be expensive. Ozempic is approved to manage Type 2 diabetes and reduce the risk of heart attacks and strokes in certain people. It’s also commonly prescribed off-label for weight loss. Look for FDA warnings.
Ozempic is a GLP-1 agonist and is actually marketed as a diabetes drug, but many physicians are prescribing it for weight loss (off label-use). Ozempic’s label warns, “In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. I’d love to hear from you!
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content